Literature DB >> 10956315

Endothelial dysfunction: the role and impact of the renin-angiotensin system.

T F Lüscher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10956315      PMCID： PMC1766535          DOI： 10.1136/heart.84.suppl_1.i20

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

1.  Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist.

Authors:  P Moreau; L V d'Uscio; S Shaw; H Takase; M Barton; T F Lüscher
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

2.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

3.  Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.

Authors:  Z Yang; N Krasnici; T F Lüscher
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

4.  Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

Authors:  G B Mancini; G C Henry; C Macaya; B J O'Neill; A L Pucillo; R G Carere; T J Wargovich; H Mudra; T F Lüscher; M I Klibaner; H E Haber; A C Uprichard; C J Pepine; B Pitt
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

5.  Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1.

Authors:  G Liu; E Espinosa; B S Oemar; T F Lüscher
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-07       Impact factor: 8.311

6.  Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function.

Authors:  L V d'Uscio; S Shaw; M Barton; T F Lüscher
Journal:  Hypertension       Date:  1998-06       Impact factor: 10.190

7.  Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.

Authors:  W Auch-Schwelk; C Bossaller; M Claus; K Graf; M Gräfe; E Fleck
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

8.  Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor.

Authors:  M R Tschudi; T F Lüscher
Journal:  Biochem Biophys Res Commun       Date:  1994-10-28       Impact factor: 3.575
  8 in total
  13 in total

Review 1.  AT1 receptor signaling pathways in the cardiovascular system.

Authors:  Tatsuo Kawai; Steven J Forrester; Shannon O'Brien; Ariele Baggett; Victor Rizzo; Satoru Eguchi
Journal:  Pharmacol Res       Date:  2017-05-17       Impact factor: 7.658

2.  Impaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene.

Authors:  Matthew J Durand; Carol Moreno; Andrew S Greene; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

3.  Renin-Angiotensin System Blockade Is Associated with Exercise Capacity, Sympathetic Activity, and Endothelial Function in Patients with Chronic Kidney Disease.

Authors:  Jin Hee Jeong; Justin D Sprick; Dana DaCosta; Arshed A Quyyumi; Jeanie Park
Journal:  Kidney Blood Press Res       Date:  2021-11-10       Impact factor: 2.687

4.  Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.

Authors:  Yingzi Zhao; Sheila Flavahan; Susan W Leung; Aimin Xu; Paul M Vanhoutte; Nicholas A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

5.  Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.

Authors:  Kultigin Turkmen; Huseyin Oflaz; Bora Uslu; Arif O Cimen; Ali Elitok; Erdem Kasikcioglu; Sabahat Alisir; Fatih Tufan; Sule Namli; Mukremin Uysal; Tevfik Ecder
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 8.237

Review 6.  ACE2, a promising therapeutic target for pulmonary hypertension.

Authors:  Vinayak Shenoy; Yanfei Qi; Michael J Katovich; Mohan K Raizada
Journal:  Curr Opin Pharmacol       Date:  2011-01-05       Impact factor: 5.547

7.  Mechanisms of endothelial dysfunction in obesity-associated hypertension.

Authors:  N S Lobato; F P Filgueira; E H Akamine; R C Tostes; M H C Carvalho; Z B Fortes
Journal:  Braz J Med Biol Res       Date:  2012-04-12       Impact factor: 2.590

Review 8.  Role of free fatty acids in endothelial dysfunction.

Authors:  Arijit Ghosh; Lei Gao; Abhimanyu Thakur; Parco M Siu; Christopher W K Lai
Journal:  J Biomed Sci       Date:  2017-07-27       Impact factor: 8.410

9.  Role of the Renin Angiotensin System in Blood Pressure Allostasis-induced by Severe Food Restriction in Female Fischer rats.

Authors:  Aline Maria Arlindo de Souza; Crystal A West; Aline Rezende Ribeiro de Abreu; Amrita V Pai; Laura Batista Tavares Mesquita; Hong Ji; Deoclécio Chianca; Rodrigo Cunha Alvim de Menezes; Kathryn Sandberg
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

10.  Impact of Renin-Angiotensin System Inhibitors on Long-Term Clinical Outcomes of Patients With Coronary Artery Spasm.

Authors:  Byoung Geol Choi; Sung Yeon Jeon; Seung-Woon Rha; Sang-Ho Park; Min Suk Shim; Se Yeon Choi; Jae Kyeong Byun; Hu Li; Jah Yeon Choi; Eun Jin Park; Sung-Hun Park; Jae Joong Lee; Sunki Lee; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Jin Won Kim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  J Am Heart Assoc       Date:  2016-07-21       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.